DNA methylation signatures in circulating cell-free DNA as biomarkers for the early detection of cancer

被引：0
作者：
Junyun Wang
Xiao Han
Yingli Sun
机构：
[1] Chinese Academy of Sciences,Key Laboratory of Genomic and Precision Medicine, China Gastrointestinal Cancer Research Center, Beijing Institute of Genomics
[2] University of Chinese Academy of Sciences,undefined
来源：
Science China Life Sciences | 2017年 / 60卷
关键词：
circulating cell-free DNA; DNA methylation; diagnostic markers; cancer detection;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Detecting cell-free DNA (cfDNA) or circulating tumor DNA (ctDNA) in plasma or serum could serve as a “liquid biopsy”, which would be useful for numerous diagnostic applications. cfDNA methylation detection is one of the most promising approaches for cancer risk assessment. Here, we reviewed the literature related to the use of serum or plasma circulating cell-free DNA for cancer diagnosis in the early stage and their power as future biomarkers.
引用
收藏
页码：356 / 362
页数：6
相关论文
共 546 条
[1]  
An Q.(2002)Detection of p16 hypermethylation in circulating plasma DNA of non-small cell lung cancer patients Cancer Lett 188 109-114
[2]  
Liu Y.(2005)Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy Clin Cancer Res 11 4037-4043
[3]  
Gao Y.(2008)CpG island hypermethylation profile in the serum of men with clinically localized and hormone refractory metastatic prostate cancer J Urol 179 529-534
[4]  
Huang J.(2002)p16INK4A Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer Clin Cancer Res 8 3782-3787
[5]  
Fong X.(2014)Utility of MLH1 methylation analysis in the clinical evaluation of lynch syndrome in women with endometrial cancer Curr Pharm Des 20 1655-1663
[6]  
Li L.(2008)Methylation-specific sequencing of GSTP1 gene promoter in circulating/extracellular DNA from blood and urine of healthy donors and prostate cancer patients Ann New York Acad Sci 1137 222-225
[7]  
Zhang D.(2008)Quantitative analysis of circulating methylated DNA as a biomarker for hepatocellular carcinoma Clin Chem 54 1528-1536
[8]  
Cheng S.(2014)Abstract 4813: DNA methylation of tumor suppressor and metastasis suppressor genes in primary tumors, circulating tumor cells and cell free DNA in the same breast cancer patients Cancer Res 74 4813-4813
[9]  
Bastian P.J.(2014)Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer Gut 63 317-325
[10]  
Palapattu G.S.(2013)Analysis of circulating tumor DNA to monitor metastatic breast cancer N Engl J Med 368 1199-1209
12345678910